EpiVario Inc. — Form D
EpiVario Inc. of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-12. The offering totals $1.5M, of which $135K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2022-09-12
- Form: D
- Accession: 0001753351-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $135K
- Remaining: $1.4M
- Investors: 3
- Date of first sale: 2022-08-26
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-458573
Issuer
- Name: EpiVario Inc.
- CIK: 0001753351
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 3401 GRAYS FERRY AVENUE BUILDING 176, PHILADELPHIA, PA, 19146
- Phone: 215-400-0133
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michael Dishowitz | Director | Philadelphia, PA |
| Thomas Kim | Director | Houston, TX |
| Thomas Kim | Executive Officer | Houston, TX |
| Eric Schultenover | Director | Philadelphia, PA |
| Yi-Yen Chen | Director | Philadelphia, PA |
| Philipp Mews | Director | Philadelphia, PA |
Other filings by this issuer (6)
More